Comparative Analysis of Cosmetic Labelling Requirements in the United States and Japan

  • Vaishnavi Ramesh Khandomalke Dayanand Education Society’s, Dayanand College of Pharmacy, Latur-413512, Maharashtra, India
  • Archana Yelmate Dayanand Education Society’s, Dayanand College of Pharmacy, Latur, Maharashtra, India – 413512.
  • Kranti Satpute Dayanand Education Society’s, Dayanand College of Pharmacy, Latur, Maharashtra, India – 413512.
  • Prakash Honrao Dayanand Education Society’s, Dayanand College of Pharmacy, Latur, Maharashtra, India – 413512.

Abstract

Cosmetic labelling regulations serve as a fundamental mechanism to ensure consumer safety, transparency, and regulatory compliance. With the expansion of international cosmetic trade, manufacturers must comply with varying regulatory frameworks across different jurisdictions. In the United States, cosmetics are regulated by the US Food and Drug Administration under the Federal Food, Drug, and Cosmetic Act and the Fair Packaging and Labeling Act. In Japan, cosmetic products are governed by the Pharmaceuticals and Medical Devices Law administered by the Ministry of Health, Labour and Welfare. This review presents a structured comparative evaluation of cosmetic labelling requirements in both countries, focusing on mandatory label elements, ingredient declaration systems, language obligations, claims regulation, warning statements, and enforcement mechanisms. The analysis identifies major similarities and regulatory differences that impact global market entry strategies.


Conclusion: Although both regulatory systems aim to protect consumer health, the United States follows a manufacturer-responsibility and post-market surveillance model, whereas Japan adopts a more prescriptive and language-specific regulatory structure. Understanding these distinctions is essential for regulatory compliance and successful international marketing.

Keywords: Cosmetics, Labelling, USFDA, MHLW, Regulatory Affairs, Comparative Review

Downloads

Download data is not yet available.

References

1. United States Congress. Federal Food, Drug, and Cosmetic Act. Washington (DC): US Government Publishing Office; 1938 Jun 25.
2. United States Congress. Fair Packaging and Labeling Act. Washington (DC): US Government Publishing Office; 1966 Nov 3.
3. Ministry of Health, Labour and Welfare. Pharmaceuticals and Medical Devices Law [Internet]. Tokyo: MHLW; 2014 Nov 25 [cited 2026 Feb 14]. Available from: https://www.mhlw.go.jp/english/policy/health-medical/pharmaceuticals/index.html
4. US Food and Drug Administration. Overview of cosmetics regulation in the United States [Internet]. Silver Spring (MD): USFDA; 2023 Jan 10 [cited 2026 Feb 14]. Available from:
https://www.fda.gov/cosmetics/cosmetics-laws-regulations
5. US Food and Drug Administration. Color additive regulations for cosmetics. Silver Spring (MD): USFDA; 2023 Jan 15.
6. Code of Federal Regulations. Title 21 Part 701 – Cosmetic Labeling. Washington (DC): US Government Publishing Office; 2024 Jan 1.
7. Ministry of Health, Labour and Welfare. Standards for cosmetics under PMDL [Internet]. Tokyo: MHLW; 2023 Apr 1 [cited 2026 Feb 14]. Available from: https://www.mhlw.go.jp/english/policy/health-medical/pharmaceuticals/
8. Ministry of Health, Labour and Welfare. Cosmetic labeling standards in Japan [Internet]. Tokyo: MHLW; 2023 May 15 [cited 2026 Feb 14]. Available from: https://www.mhlw.go.jp/english/topics/cosmetics/
9. Ministry of Health, Labour and Welfare. Guidance on cosmetic and quasi-drug claims [Internet]. Tokyo: MHLW; 2023 Aug 1 [cited 2026 Feb 14]. Available from: https://www.mhlw.go.jp/english/policy/health-medical/pharmaceuticals/
10. US Food and Drug Administration. FDA authority over cosmetics: how cosmetics are regulated [Internet]. Silver Spring (MD): FDA; 2025 Mar 25 [cited 2026 Mar 25]. Available from:
https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated
11. JpnPro Consultants. Cosmetics and quasi-drugs regulatory requirements in Japan [Internet]. Tokyo: JpnPro; 2022 Sep 10 [cited 2026 Mar 25]. Available from: https://www.jpnpro.com/en/services/cosmetics-regulations
12. Japan Cosmetic Industry Association. Regulatory compliance and manufacturing standards for cosmetics [Internet]. Tokyo: JCIA; 2023 Sep 5 [cited 2026 Mar 25]. Available from:
https://www.jcia.org/en/regulations/
13. Ministry of Health, Labour and Welfare. Import and marketing authorization requirements for cosmetics [Internet]. Tokyo: MHLW; 2023 Jun 20 [cited 2026 Feb 14]. Available from: https://www.mhlw.go.jp/english/policy/health-medical/pharmaceuticals/import/
14. US Food and Drug Administration. Cosmetic ingredient labeling guide [Internet]. Silver Spring (MD): USFDA; 2023 Feb 5 [cited 2026 Feb 14]. Available from: https://www.fda.gov/cosmetics/labeling
15. Japan Cosmetic Industry Association. Japanese labeling names for cosmetic ingredients [Internet]. Tokyo: JCIA; 2023 Mar 10 [cited 2026 Feb 14]. Available from: https://www.jcia.org/en/standards/ingredient-names/
16. Japan Cosmetic Industry Association. Standards for cosmetic ingredient nomenclature [Internet]. Tokyo: JCIA; 2023 Mar 15 [cited 2026 Feb 14]. Available from: https://www.jcia.org/en/standards/
17. US Food and Drug Administration. Misbranding and false claims guidance [Internet]. Silver Spring (MD): USFDA; 2023 Jul 12 [cited 2026 Feb 14]. Available from: https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement
18. US Food and Drug Administration. Warning statements for cosmetic products [Internet]. Silver Spring (MD): USFDA; 2023 Oct 2 [cited 2026 Feb 14]. Available from: https://www.fda.gov/cosmetics/labeling
19. US Food and Drug Administration. Cosmetic compliance and enforcement activities [Internet]. Silver Spring (MD): USFDA; 2023 Dec 1 [cited 2026 Feb 14]. Available from: https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement
Statistics
7 Views | 0 Downloads
How to Cite
1.
Khandomalke VR, Yelmate A, Satpute K, Honrao P. Comparative Analysis of Cosmetic Labelling Requirements in the United States and Japan. Int J Drug Reg Affairs [Internet]. 2026Jun.19 [cited 2026Jun.20];14(2):90-3. Available from: https://www.ijdra.com/index.php/journal/article/view/894